Skroutz.mt

Comen Phototherapy Unit
Phototherapy Devices

Comen Phototherapy Unit Code: BL70

Key features:

  • High-intensity cool blue LED
  • Maximum radiation 63 μW/cm²/nm
  • 5 intensity adjustment levels
  • LED lifespan of 50,000 hours
  • Peak spectrum 449–461 nm
  • Uniform body coverage
See full description
990 00 €
Delivery by Wed, 24 Jun
14,00 €   shipping cost
Sent from Greece
From Digas
Greece
See Medical Equipment on the page of Digas
Review the product
Product report

Description

Description

LED Neonatal Phototherapy BL70 Medcare Visions

  • LED phototherapy for safe and quick treatment of hyperbilirubinemia in premature and term infants.
  • Equipped with a high-intensity cold LED light source with minimal heat production, ideal for prolonged therapy.
  • Maximum radiation of 63μW/cm²/nm, enhancing the degradation of bilirubin and reducing treatment time.
  • Five levels of radiation adjustment for customized therapy.
  • LED lifespan of up to 50,000 hours for uninterrupted clinical use.
  • Peak wavelength spectrum at 449 – 461 nm, the most effective in reducing unconjugated bilirubin.
  • Removal of harmful UV months from the spectrum, ideal for treating neonatal jaundice.
  • Uniform radiation distribution across the body surface for intensive phototherapy.

Capabilities

The LED Phototherapy is a reliable and safe solution for the immediate treatment of hyperbilirubinemia in premature and full-term newborns. It uses high-intensity cold therapeutic LED light, with minimal thermal load, making it suitable for prolonged and intensive treatments. With a wavelength of 449–461 nm — optimal for breaking down unconjugated bilirubin — it ensures quick and effective results.

Features

  • LED Phototherapy for safe and rapid treatment of hyperbilirubinemia in preterm and full-term infants.
  • Equipped with a high-intensity cold LED light source with minimal heat production, ideal for long-term therapy.
  • Maximum radiation of 63μW/cm²/nm, enhances bilirubin breakdown and reduces treatment time.
  • Five levels of radiation adjustment for customized therapy.
  • Peak wavelength spectrum at 449 – 461 nm, most effective in reducing unconjugated bilirubin.
  • Removal of harmful UV wavelengths from the spectrum, ideal for treating neonatal jaundice.
  • Uniform radiation distribution on the body's surface for intensive phototherapy.

Manufacturer

Manufacturer Details

Warnings & Safety Information
See full description

Description

LED Neonatal Phototherapy BL70 Medcare Visions

  • LED phototherapy for safe and quick treatment of hyperbilirubinemia in premature and term infants.
  • Equipped with a high-intensity cold LED light source with minimal heat production, ideal for prolonged therapy.
  • Maximum radiation of 63μW/cm²/nm, enhancing the degradation of bilirubin and reducing treatment time.
  • Five levels of radiation adjustment for customized therapy.
  • LED lifespan of up to 50,000 hours for uninterrupted clinical use.
  • Peak wavelength spectrum at 449 – 461 nm, the most effective in reducing unconjugated bilirubin.
  • Removal of harmful UV months from the spectrum, ideal for treating neonatal jaundice.
  • Uniform radiation distribution across the body surface for intensive phototherapy.

Capabilities

The LED Phototherapy is a reliable and safe solution for the immediate treatment of hyperbilirubinemia in premature and full-term newborns. It uses high-intensity cold therapeutic LED light, with minimal thermal load, making it suitable for prolonged and intensive treatments. With a wavelength of 449–461 nm — optimal for breaking down unconjugated bilirubin — it ensures quick and effective results.

Features

  • LED Phototherapy for safe and rapid treatment of hyperbilirubinemia in preterm and full-term infants.
  • Equipped with a high-intensity cold LED light source with minimal heat production, ideal for long-term therapy.
  • Maximum radiation of 63μW/cm²/nm, enhances bilirubin breakdown and reduces treatment time.
  • Five levels of radiation adjustment for customized therapy.
  • Peak wavelength spectrum at 449 – 461 nm, most effective in reducing unconjugated bilirubin.
  • Removal of harmful UV wavelengths from the spectrum, ideal for treating neonatal jaundice.
  • Uniform radiation distribution on the body's surface for intensive phototherapy.

Manufacturer

Comen - Phototherapy Devices Comen

Manufacturer Details

Warnings & Safety Information
990,00 €
14,00 €   shipping cost